Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Mitogen-activated protein kinase 14 | ||
| Ligand | BDBM50376237 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_475725 (CHEMBL934611) | ||
| IC50 | 24±n/a nM | ||
| Citation |  Das, J; Moquin, RV; Pitt, S; Zhang, R; Shen, DR; McIntyre, KW; Gillooly, K; Doweyko, AM; Sack, JS; Zhang, H; Kiefer, SE; Kish, K; McKinnon, M; Barrish, JC; Dodd, JH; Schieven, GL; Leftheris, K Pyrazolo-pyrimidines: a novel heterocyclic scaffold for potent and selective p38 alpha inhibitors. Bioorg Med Chem Lett18:2652-7 (2008) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Mitogen-activated protein kinase 14 | |||
| Name: | Mitogen-activated protein kinase 14 | ||
| Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
| Type: | Serine/threonine-protein kinase | ||
| Mol. Mass.: | 41286.76 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | Q16539 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50376237 | |||
| n/a | |||
| Name | BDBM50376237 | ||
| Synonyms: | CHEMBL409328 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C23H24N6O | ||
| Mol. Mass. | 400.4763 | ||
| SMILES | CNC(=O)c1ccc(C)c(Nc2ncnc3n(ncc23)-c2c(C)cc(C)cc2C)c1 |(20.89,3.58,;19.55,4.34,;18.22,3.57,;18.22,2.03,;16.89,4.34,;16.88,5.89,;15.54,6.66,;14.21,5.89,;12.88,6.65,;14.21,4.34,;12.88,3.57,;12.88,2.03,;14.2,1.27,;14.21,-.26,;12.87,-1.04,;11.54,-.27,;10.07,-.74,;9.17,.5,;10.07,1.75,;11.53,1.27,;9.29,-2.07,;7.75,-2.05,;6.99,-.71,;6.97,-3.38,;7.73,-4.72,;6.95,-6.04,;9.27,-4.73,;10.05,-3.4,;11.59,-3.41,;15.54,3.57,)| | ||
| Structure | 
| ||